Join us as we speak with Dr. Vincent Rajkumar, MD of the Mayo Clinic about obesity and race in multiple myeloma.

Join us as we talk with Dr. Jonathan Licht of the Robert H. Lurie Comprehensive Cancer Center and Northwestern University about high risk myeloma.

Join us as we talk with Dr. Aaron Rapoport, MD of the University of Maryland Greenbaum Cancer Center about his vaccine approaches and T-cell research in myeloma.

Join us as we talk with Dr. Robert Z. Orlowski, MD, PhD of MD Anderson Cancer about immunotherapies and the latest in his myeloma research.

Join us as we talk with Dr. Leif Bergsagel about his research to subdivide myeloma by genetic type and apply different therapy approaches to these unique variations of myeloma.

Learn why myeloma is so genetically complicated and the implications this has for personalized medicine in myeloma. Dr. Lohr, MD, PhD of the Dana Farber Cancer Institute and BROAD Institue recently published an article in Cancer Cell describing the complexity and what it means for myeloma patients.

Listen as we talk with Dr. Phillip McCarthy of the Roswell Park Cancer Institute about his work in immunotherapy, transplantation and myeloma care.

Join us as we talk with Dr. Damian Green about radiation, radioimmunotherapy and how progress is being made for high-risk patients in myeloma treatment today.

Join us as we talk with Dr. Damian Green about radiation, radioimmunotherapy and how progress is being made for high-risk patients in myeloma treatment today.

Join us as we talk with Dr. ParameswaranHari, MD, MRCP, MS, about transplants, his latest myeloma research and open clinical trials. Dr. Hari is the Armand Quick-William Stapp Professor of Hematology, Section Head of Hematological Malignancies and the Director of the Adult Blood and Marrow Transplant Program at the Medical College of Wisconsin.